Porsche Cars North America and Porsche AG of Stuttgart, Germany to Support the Quail Porsche Race Car Classic

SAN FRANCISCO, Sept. 10 /PRNewswire/ -- Bonnie Addario of The Bonnie J. Addario Lung Cancer Foundation and Dr. David Jablons, Director of the UCSF Thoracic Oncology Program are honored to announce today that Porsche will be a major collaborator in the October 16, 2011 exclusive QUAIL PORSCHE RACE CAR CLASSIC in Carmel, California at the famed Quail Lodge and Golf Club. This once-in-a-lifetime gathering of vintage Porsche race cars from 1950-1965 coming from around the globe will raise critical funding to directly support lung cancer research. With 3,500 attendees expected, it is anticipated to be a sell out event. Please see event website for more information: http://www.2011PorscheRaceCarClassic.com

Porsche Company North America (PCNA) and Porsche AG will be providing support in a number of ways including: logistical and marketing support, distribution of materials, on-site vehicles and more.  In addition, Porsche will bring several special cars from the Porsche Museum in Stuttgart.

About Lung Cancer

Lung Cancer kills more people each year than the other major cancers combined (approx 160,000 people per year in the U.S. alone). And, despite popular belief, 60% of Lung Cancer patients are former—not current—smokers and another 20% never smoked at all.  (CDC-Center of Disease Control).  Despite its deadliness, Lung Cancer research is the least funded of the major cancers. All net proceeds from ticket sales, as well as sponsor contributions, will go directly to Lung Cancer research to expedite improving survival and extending lives.

About Porsche Cars North America, Inc:

Porsche Cars North America, Inc. (PCNA), based in Atlanta, Ga., is the exclusive importer of Porsche vehicles for the United States. PCNA is a wholly owned, indirect subsidiary of Dr. Ing.h.c. F. Porsche AG. It employs 213 people who provide Porsche vehicles, parts, service, marketing and training for its 199 dealers. The dealers, in turn, provide Porsche owners with best-in-class service. Throughout its more than six-decade history, Porsche has developed numerous technologies that have advanced vehicle performance, improved safety and spurred environmental innovations within the automotive industry. The company continues to celebrate its heritage by adding to its long list of motorsports victories dating back to its first 24 Hours of Le Mans class win in 1951. Today, with more than 28,000 victories, Porsche is recognized as the world's most successful brand in sports car racing.  PCNA, which imports the iconic 911 series, the highly acclaimed Boxster and Cayman mid-engine sports cars, high-end Cayenne sport utility vehicles and the four-door Panamera Gran Turismos, strives to maintain a standard of excellence, commitment and distinction synonymous with its brand.

About Bonnie J. Addario Lung Cancer Foundation http://www.lungcancerfoundation.org

Since it's inception on March 6, 2006, BJALCF has grown into the first international collaborative entity of its kind, raising over $4 million in its first four years and funding lung cancer research and early detection programs in many states and other countries. BJALCF hopes to become the global leader in the Lung Cancer movement. Two years after BJALCF began, the Addario Lung Cancer Medical Institute (ALCMI) was created to connect the top thought leaders, scientists, researchers, and physicians from eight institutions worldwide, to date, and has engaged community hospitals to lead and empower patients toward better treatment options. Only immediate results-oriented projects or programs promising to catalyze progress through early detection, genetic testing, drug discovery and patient-focused outcomes are considered. The ultimate goal of BJALCF is to increase the inexcusably low survival rate of lung cancer by becoming the largest source of non-profit funding dedicated to turning lung cancer into a manageable chronic disease in our lifetime.

About The UCSF Thoracic Oncology Program:

Lung cancer is the leading cause of cancer death worldwide and the Thoracic Oncology Program is poised to conquer it. UCSF provides state-of-the-art care to patients with lung cancer, mesothelioma, esophageal cancer, sarcoma and cancer that has metastasized to the chest. The program is led by David M. Jablons, M.D., Chief of the Section of General Thoracic Surgery and Program Leader of the Thoracic Oncology Program. Patients receive treatment from a dedicated multidisciplinary team of specialists. At UCSF, one of the world's leading biomedical research centers, patients also have access to clinical trials for promising new drugs.  http://top.ucsf.edu

SOURCE Bonnie J. Addario Lung Cancer Foundation